|
Serotype (number of isolates)
|
Clinical origin (number of isolates)
|
Number (%) of bac(+) isolates
|
Number (%) of bca(+) isolates
|
Number (%) of bac(+)/bca(+) isolates
|
Number (%) of bac(-)/bca(-) isolates
|
|---|
|
Ia (120)
|
Colonization (55)
|
1 (1.8%)
|
31 (56.4%)
|
6 (10.9%)
|
17 (30.9%)
|
|
Infection (65)
|
2 (3.1%)
|
26 (40%)
|
3 (4.6%)
|
34 (52.3%)
|
|
Ib (81)
|
Colonization (53)
|
1 (1.9%)
|
23 (43.4%)
|
10 (18.9%)
|
19 (35.8%)
|
|
Infection (28)
|
0
|
10 (35.7%)
|
8 (28.6%)
|
10 (35.7%)
|
|
II (83)
|
Colonization (52)
|
2 (3.8%)
|
26 (50%)
|
8 (15.4%)
|
16 (30.8%)
|
|
Infection (31)
|
0
|
12 (38.7%)
|
2 (6.5%)
|
17 (54.8%)
|
|
III (29)
|
Colonization (15)
|
2 (13.3%)
|
7 (46.7%)
|
0
|
6 (40%)
|
|
Infection (14)
|
0
|
3 (21.4%)
|
0
|
11 (78.6%)
|
|
IV (35)
|
Colonization (18)
|
0
|
11 (61.1%)
|
2 (11.1%)
|
5 (27.8%)
|
|
Infection (17)
|
0
|
9 (52.9%)
|
1 (5.9%)
|
7 (41.2%)
|
|
V (59)
|
Colonization (42)
|
1 (2.4%)
|
18 (42.8%)
|
2 (4.8%)
|
21 (50%)
|
|
Infection (17)
|
0
|
3 (17.6%)
|
1 (5.9%)
|
13 (76.5%)
|
|
NTa (27)
|
Colonization (14)
|
1 (7.1%)
|
6 (42.9%)
|
4 (28.6%)
|
3 (21.4%)
|
|
Infection (13)
|
0
|
4 (30.8%)
|
0
|
9 (69.2%)
|
|
Total (434)
|
Colonization (249)
|
8 (3.2%)
|
122 (49%)
|
32 (12.9%)
|
87 (34.9%)
|
|
Infection (185)
|
2 (1.1%)
|
67 (36.2%)
|
15 (8.1%)
|
101 (54.6%)
|
-
aNT, nontypeable by using antisera against Ia, Ib, II-VIII serotypes.
- All the 434 isolates, regardless serotype, were positive for the scpB and lmb virulence-associated genes.
